Important

Following the security measures legally established to prevent infection with the COVID-19 virus, the DBGen Ocular Genomics team will work remotely via telematics and reduce considerably the work in the lab. Queries and information requests will be addressed via email info@dbgen.com.

The DBGen Team (Barcelona 16/03/2020)

DBGen is a company that is devoted to genetic testing of hereditary eye diseases in a way that combines quality, diagnostic efficiency and engagement between the patient, the ophthalmologist and the companies requiring its services.

At DBGen we offer a quality, reliable and affordable genetic diagnosis that secures the clinical diagnosis and can guide the patient toward the right emerging therapies for genetic eye diseases. The genetic diagnosis can be used to identify asymptomatic relatives who carry the genetic defect, and is an essential step to provide genetic counseling.

 

Achromatopsia

 

Albinism

 

Glaucoma

 

Macular dystrophy

 

Retinitis pigmentosa

 

Non-affected vision

excellence in research and service
decisive commitment to the patient’s quality of life
genetic diagnosis applied to precision medicine

Team and experience

The company was founded by a team of specialized researchers in genetics at the University of Barcelona, who have been conducting basic research on genetic diseases of the retina for over 25 years.

Our team, which also includes experts in communications and management, as well as qualified technicians, is devoted to basic research and has contributed, through numerous publications, to identifying new pathogenic genes and mutations, and to building DNA diagnostic chips. The increased social demand for accurate genetic diagnoses from patients, associations and ophthalmologists is what drove us to create this genetic diagnostic service as a spin-off of the University of Barcelona.

Meet our team

350 MILLION
people are living with rare diseases
75%
are children
Blindness in children
6 out of 10
cases are inherited
6.000 - 8.000
Rare
diseases

>500 causative
genes

Collaborators and clients

APEC Hospital de la Ceguera (México)
Centre d’Oftalmologia Barraquer
Centro de la Visión – Clínica Las Condes (Chile)
CNAG
Es Retina Asturias
Fundació Bosch i Gimpera
Hospital Clínic de Barcelona
Hospital de Sabadell Parc Taulí
Hospital Germans Trias i Pujol
Hospital Sant Joan de Déu
Institut Català de Retina (ICR)
Instituto Universitario de Oftalmobiología Aplicada (IOBA)
Quirónsalud
Stargardt APNES – Retina Argentina
StargardtGo – PedRetina
Universitat de Barcelona

What our clients say

DBGen fully aware that a molecular diagnosis is vitally important to a patient with retinal dystrophies, and undertakes its work with complete professionalism and responsibility, and, of course, empathy. They are available to address all your questions and concerns. You cannot choose a better place than DBGen to treat these cases. Marcela Ciccioli – President of Stargardt APNES Retina Argentina
Our relationship with DBGen is extremely satisfactory. As a reference Paediatrics’ Hospital in Spain, we regularly examine patients affected with different inherited ophthalmological disorders who require genetic testing. DBGen exhaustive genetic reports are instrumental for patient management and genetic counselling of the families. Our diagnosed patients may benefit from this partnership since they are being considered for recruitment in gene therapy trials. Jaume Català-Mora MD, PhD – Hospital Sant Joan de Déu. Barcelona, Spain
DBGen is our top provider of genetic diagnoses since 2016. The team at DBGen is fully committed to applying their long-standing experience and expertise to study the diagnoses of inherited visual disorders. They successfully combine the latest advances in the field with state-of-the-art massive sequencing to offer high yield genetic diagnosis, even in complex cases. This company adds top value by merging high quality standards and a close interaction with physicians and patients. Jeroni Nadal MD, PhD and Dr. Juan José Rodríguez Ezcurra MD – Barraquer Ophthalmology Centre. Barcelona, Spain
We are delighted with the alliance established with DBGen, and with their enormous interest in each case. As a Department of Oculogenetics, we attend more than 200 patients per year with inherited retinal dystrophies, and we have been able to clarify and finally achieve the diagnosis of very complex cases and thus been able to carry out adequate genetic counselling thanks to the joint effort with DBGen. René Moya MD, MSc – Clínica Las Condes, Santiago de Chile, Chile
DBGen Ocular Genomics delivers high quality care and management of ophthalmic genetic diagnoses. DBGen’s high standards and knowledge of hereditary ophthalmological pathology allows them to successfully resolve my genetic diagnoses. In addition, DBGen delivers promptly and their services are competitively priced. Rosa M. Coco MD, PhD. – Institute of Applied Ophthalmobiology (IOBA), Valladolid, Spain
The high scientific standards of the DBGen team, the advanced technology of its diagnostic methodologies, its extensive track record in the genetic diagnosis of eye diseases, its human quality and its closeness and accessibility, always showing a specific interest for each patient, trying to reach new milestones in the precision of the analysis results, are worthy of our total trust when requesting genetic diagnosis for our patients. Lorena Castillo MD, PhD – Institut Català de Retina (ICR), Barcelona, Spain

Accreditations & Certifications

Genetic diagnosis laboratory authorized by the Government of Catalonia Department of Health (E08709630), certified according to the ISO 9001:2015 standard (ES20/87394) and awarded with the highest rating by the Genomics Quality Assessment (GenQA) EQA provider.

Accreditations & Certifications

Awards

The work of DBGen Ocular Genomics has been recognised with the following honors and awards

Awards

Who our services are for

Hospital ophthalmology units
Ophthalmology centers and clinics
Companies specializing in gene therapy
Associations of patients with hereditary ocular disorders
Patients with genetic eye disabilities